NCT04511039 2026-03-02Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerRoswell Park Cancer InstitutePhase 1 Recruiting45 enrolled